Chandra P. Belani

30.4k total citations · 4 hit papers
458 papers, 22.0k citations indexed

About

Chandra P. Belani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Chandra P. Belani has authored 458 papers receiving a total of 22.0k indexed citations (citations by other indexed papers that have themselves been cited), including 307 papers in Pulmonary and Respiratory Medicine, 292 papers in Oncology and 101 papers in Molecular Biology. Recurrent topics in Chandra P. Belani's work include Lung Cancer Treatments and Mutations (248 papers), Lung Cancer Research Studies (133 papers) and Lung Cancer Diagnosis and Treatment (116 papers). Chandra P. Belani is often cited by papers focused on Lung Cancer Treatments and Mutations (248 papers), Lung Cancer Research Studies (133 papers) and Lung Cancer Diagnosis and Treatment (116 papers). Chandra P. Belani collaborates with scholars based in United States, Italy and Canada. Chandra P. Belani's co-authors include Joan H. Schiller, Alan Sandler, Corey J. Langer, David H. Johnson, Suresh S. Ramalingam, James E. Krook, David Harrington, Junming Zhu, Roy S. Herbst and Mark G. Kris and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Chandra P. Belani

450 papers receiving 21.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

2002 4.1k citations Joan H. Schiller, Chandra P. Belani et al. profile →
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

2003 2.1k citations Chandra P. Belani, Joan H. Schiller et al. profile →
Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study

2009 832 citations Christoph Zielinski, Yi‐Long Wu et al. profile →
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group

2003 763 citations Frank V. Fossella, Chandra P. Belani et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Chandra P. Belani

Since Specialization

Citations

This map shows the geographic impact of Chandra P. Belani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chandra P. Belani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chandra P. Belani more than expected).

Fields of papers citing papers by Chandra P. Belani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chandra P. Belani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chandra P. Belani. The network helps show where Chandra P. Belani may publish in the future.

Co-authorship network of co-authors of Chandra P. Belani

This figure shows the co-authorship network connecting the top 25 collaborators of Chandra P. Belani. A scholar is included among the top collaborators of Chandra P. Belani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chandra P. Belani. Chandra P. Belani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population‐based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic disease 2018 ·Cancer Medicine ·John M. Varlotto, (unknown), (unknown), John C. Flíckinger, Malcolm M. DeCamp, Debra Maddox, Paul Rava, Thomas J. FitzGerald, (unknown), (unknown), Paulo J. Oliveira, Suhail M. Ali, Chandra P. Belani, (unknown), Heather A. Wakelee, Manali I. Patel, Jennifer Baima, Jianying Zhang, William Walsh	23
2	Dynamic change of fatigue of pemetrexed maintenance treatment in the JMEN trial 2017 ·Lung Cancer ·Li Zhang, Chandra P. Belani, (unknown), Xin Wang, Lulu Yang, Mauro Orlando, Yi‐Long Wu	2
3	National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Kristin Higgins, Kelli O’Connell, Yuan Liu, Theresa Gillespie, Mark W. McDonald, Rathi N. Pillai, Kirtesh R. Patel, Pretesh Patel, Clifford G. Robinson, Charles B. Simone, Taofeek K. Owonikoko, Chandra P. Belani, Fadlo R. Khuri, Walter J. Curran, Suresh S. Ramalingam, Madhusmita Behera	91
4	Pulmonary Rehabilitation in Lung Cancer 2016 ·PM&R ·Hongmei Wang, Xin Liu, Shawn J. Rice, Chandra P. Belani	26
5	Tid1, the Mammalian Homologue of Drosophila Tumor Suppressor Tid56, Mediates Macroautophagy by Interacting with Beclin1-containing Autophagy Protein Complex 2015 ·Journal of Biological Chemistry ·(unknown), Huan Zhang, Dan Liŭ, Li Chen, Chandra P. Belani, Hong‐Gang Wang, Hua Cheng	13
6	A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent 2014 ·Clinical Cancer Research ·Leonard J. Appleman, Sanjeeve Balasubramaniam, Robert A. Parise, (unknown), Christophe E. Redon, Asako Nakamura, William M. Bonner, James R. Wright, Richard Piekarz, David Köhler, Yixing Jiang, Chandra P. Belani, Julie L. Eiseman, Edward Chu, Jan H. Beumer, Susan E. Bates	5
7	A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas 2012 ·Clinical Cancer Research ·Shivaani Kummar, Jiuping Ji, Robert J. Morgan, Heinz-Josef Lenz, Shannon L. Puhalla, Chandra P. Belani, David R. Gandara, Deborah Allen, Brian F. Kiesel, Jan H. Beumer, Edward M. Newman, Larry Rubinstein, Alice P. Chen, Yiping Zhang, Lihua Wang, Robert J. Kinders, Ralph E. Parchment, Joseph E. Tomaszewski, James H. Doroshow	155
8	Differential effect of age on survival in advanced NSCLC in women versus men: Analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab 2012 ·Lung Cancer ·Heather A. Wakelee, Suzanne E. Dahlberg, Julie R. Brahmer, Joan H. Schiller, Michael C. Perry, Corey J. Langer, Alan B. Sandler, Chandra P. Belani, David H. Johnson	26
9	Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non–Small-Cell Lung Cancer: A California Cancer Consortium Trial 2011 ·Clinical Lung Cancer ·Primo N. Lara, Jeff Longmate, Karen L. Reckamp, Barbara J. Gitlitz, Athanassios Argiris, Suresh S. Ramalingam, Chandra P. Belani, Philip C. Mack, Derick Lau, (unknown), James R. Wright, Frances A. Shepherd, Natasha B. Leighl, David R. Gandara	17
10	Population Pharmacokinetics of Pegylated Liposomal CKD‐602 (S‐CKD602) in Patients With Advanced Malignancies 2011 ·The Journal of Clinical Pharmacology ·Huali Wu, Ramesh K. Ramanathan, Beth A. Zamboni, Sandra Strychor, Suresh S. Ramalingam, Robert P. Edwards, David Friedland, Ronald G. Stoller, Chandra P. Belani, (unknown), Yung‐Jue Bang, William C. Zamboni	30
11	Pemetrexed is more effective in patients with nonsquamous non-small cell lung cancer (NSCLC) histology: an analysis of three large, randomized, phase III trials 2009 ·Journal of Thoracic Oncology ·Giorgio V. Scagliotti, Thomas Brodowicz, Frances A. Shepherd, Christoph Zielinski, Johan Vansteenkiste, Christian Manegold, Lorinda Simms, Frank V. Fossella, Katherine P. Sugarman, Chandra P. Belani	3
12	Outcomes for Elderly, Advanced-Stage Non–Small-Cell Lung Cancer Patients Treated With Bevacizumab in Combination With Carboplatin and Paclitaxel: Analysis of Eastern Cooperative Oncology Group Trial 4599 2007 ·Journal of Clinical Oncology ·Suresh S. Ramalingam, Suzanne E. Dahlberg, Corey J. Langer, Robert J. Gray, Chandra P. Belani, Julie R. Brahmer, Alan B. Sandler, Joan H. Schiller, David H. Johnson	251
13	Evaluation of Plasma Insulin-like Growth Factor Binding Protein 2 and Her-2 Extracellular Domain as Biomarkers for 17-Allylamino-17-Demethoxygeldanamycin Treatment of Adult Patients with Advanced Solid Tumors 2007 ·Clinical Cancer Research ·Julie L. Eiseman, Jianxia Guo, Ramesh K. Ramanathan, Chandra P. Belani, David B. Solit, Howard I. Scher, S. Percy Ivy, Eleanor G. Zuhowski, Merrill J. Egorin	10
14	Radiofrequency ablation for the treatment of non–small cell lung cancer in marginal surgical candidates 2005 ·Journal of Thoracic and Cardiovascular Surgery ·Hiran C. Fernando, Alberto de Hoyos, Rodney J. Landreneau, Sébastien Gilbert, William E. Gooding, Percival O. Buenaventura, Neil A. Christie, Chandra P. Belani, James D. Luketich	165
15	Skin rash and good performance status predict improved survival with gefitinib in patients with advanced non-small cell lung cancer 2005 ·Annals of Oncology ·Mahfuzah Mohamed, Suresh S. Ramalingam, Yan Lin, William E. Gooding, Chandra P. Belani	71
16	Adjuvant and neoadjuvant therapy in non-small cell lung cancer 2005 ·Seminars in Oncology ·Chandra P. Belani	24
17	A phase III randomized study of carboplatin and paclitaxel with or without amifostine in patients with non-small cell lung cancer (NSCLC) 2000 ·Lung Cancer ·Chandra P. Belani, Rafat Ansari, JN Atkins, Jeremy K. Hon, Manuel Modiano, Thomas Budd	1
18	Minimally invasive surgical biopsy confirms PET findings in esophageal cancer 1997 ·Surgical Endoscopy ·James D. Luketich, Philip R. Schauer, (unknown), D. Townsend, Chandra P. Belani, Carolyn C. Meltzer, Peter F. Ferson, Robert J. Keenan	13
19	Etoposide: current status and future perspectives in the management of malignant neoplasms 1994 ·Cancer Chemotherapy and Pharmacology ·Chandra P. Belani, L. Austin Doyle, Joseph Aisner	73
20	Carboplatin dose optimization (I: Reply) 1990 ·Journal of Clinical Oncology ·Chandra P. Belani, Merrill J. Egorin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact